EFMC-ASMC'17

Conferences > Archives > EFMC-ASMC'17
Sunday August 27, 2017
09:30Excursion 1
14:00Registration
14:00Excursion 2
17:00Opening
Karin BRINER (NOVARTIS, Cambridge, United States)
Erick M. CARREIRA (ETH ZÜRICH, Zürich, Switzerland)
Koen AUGUSTYNS (UNIVERSITY OF ANTWERP, Antwerp, Belgium)
Gene VAISBERG (CHEMBRIDGE CORPORATION, San Diego, United States)
Thierry LANGER (UNIVERSITY OF VIENNA, Vienna, Austria)
17:15Opening Lecture
T01 - Photochemistry and Photopharmacology in Medicine
Dirk TRAUNER
(NEW YORK UNIVERSITY, New York, United States)
18:30Welcome Reception
Monday August 28, 2017
Session chair
Erick M. CARREIRA
(ETH ZÜRICH, Zürich, Switzerland)
08:30T02 - Next-Generation Small Molecule Therapeutics
James E BRADNER
(NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, Cambridge, MA, United States)
09:15T03 - Drugging the Undruggable
Mark BUNNAGE
(VERTEX PHARMACEUTICALS, Boston, United States)
10:00OC01 - Stereoselective Peptide Modifications – Efficient Tools for Natural Product and Drug Synthesis
Uli KAZMAIER
(SAARLAND UNIVERSITY, Saarbrücken, Germany)
10:15Coffee Break and Exhibition
10:45T04 - Bioinspired Asymmetric Catalysis
Helma WENNEMERS
(ETH ZURICH, Zürich, Switzerland)
11:30T05 - Strategies to Facilitate the Discovery of Novel CNS PET Ligands
Lei ZHANG
(PFIZER, Cambridge, United States)
12:15OC02 - Chemically Induced Degradation of the Oncogenic Transcription Factor BCL6
Peter ETTMAYER
(BOEHRINGER-INGELHEIM, Vienna, Austria)
12:30Lunch and Exhibition
13:30Poster Session 1
Session chair
Helma WENNEMERS
(ETH ZURICH, Zürich, Switzerland)
14:30T06 - Single Electron Processes to Enable Organic Synthesis
Gary A. MOLANDER
(UNIVERSITY OF PENNSYLVANIA, Philadelphia, United States)
15:15T07 - Beta-secretase Inhibitors as a Therapy for Alzheimer’s Disease – Where Are We Now?
Roland BÜRLI
(ASTRAZENECA, Cambridge, United Kingdom)
15:45OC03 - Mimicking Nature Complexity with 3D-Fragments Assembly
Hugues LEMOINE
(EDELRIS, LYON, France)
16:15Coffee Break and Exhibition
16:45PRIZE winner EFMC-YMCS 2016
OC04 - Development of Highly Selective and Reversible Diacylglycerol Lipase Inhibitors
Freek JANSSEN
(LEIDEN UNIVERSITY, Nijmegen, The Netherlands)
17:00T08 - Idea2Data: Augmenting Drug Discovery Efforts through Synthetic Reaction Data Mining and Automation
Christos A. NICOLAOU
(ELI LILLY, Indianapolis, United States)
17:45T09 - A RaPID Way to Discover Pseudo-natural Peptides
Hiroaki SUGA
(UNIVERSITY OF TOKYO, Tokyo, Japan)
18:30Closing of the day
Tuesday August 29, 2017
Session chair
Koen AUGUSTYNS
(UNIVERSITY OF ANTWERP, Antwerp, Belgium)
08:30T10 - Azidoperfluoroalkanes - Neglected, Stable and Useful Fluorinated Synthons
Petr BEIER
(ACADEMY OF SCIENCES OF THE CZECH REPUBLIC, Prague, Czech Republic)
09:15T11 - HIV-1 Maturation Inhibitors
Nicholas MEANWELL
(BRISTOL-MYERS SQUIBB, Wallingford, United States)
10:00OC05 - Discovery of RG7314, a Vasopressin 1a Receptor Antagonist for the Treatment of Social Communication Deficits in Autism Spectrum Disorders
Patrick SCHNIDER
(F. HOFFMANN-LA ROCHE, Basel, Switzerland)
10:15Coffee Break and Exhibition
10:45T12 - Organic Synthesis with Rearrangements - Adventures in Total Synthesis
Nuno MAULIDE
(UNIVERSITY OF VIENNA, Vienna, Austria)
11:30T13 - Isosteric-Switch Strategies: New Concepts and Recent Advances
Thomas C. FESSARD
(SPIROCHEM AG, Zurich, Switzerland)
12:15OC06 - Expanding Screening Decks by Innovative MCR Scaffolds
Alexander DÖMLING
(UNIVERSITY OF GRONINGEN, Groningen, The Netherlands)
12:30Lunch and Exhibition
13:30Poster Session 2
Session chair
Gene VAISBERG
(CHEMBRIDGE CORPORATION, San Diego, United States)
14:30T14 - Iron(III)-Catalyzed Carbonyl-Olefin Metathesis
Corinna SCHINDLER
(UNIVERSITY OF MICHIGAN, Ann Arbor, United States)
15:15T15 - Ring Construction by Pd-catalyzed C(sp3)-H Activation
Olivier BAUDOIN
(UNIVERSITY OF BASEL, Basel, Switzerland)
16:00OC07 - The Discovery of Soluble Guanylate Cyclase Stimulators for the Treatment of Pulmonary Arterial Hypertension
Subharekha RAGHAVAN
(MSD, Kenilworth, New Jersey, United States)
16:15Coffee Break and Exhibition
16:45T16 - Merck Drug Discovery through Enabling Capabilities
Petr VACHAL
(MSD, Kenilworth, United States)
17:30T17 - Adventures in Catalysis: from Mechanisms to Applications
Franziska SCHOENEBECK
(RWTH AACHEN, Aachen, Germany)
18:15Closing of the day
Wednesday August 30, 2017
Session chair
Thierry LANGER
(UNIVERSITY OF VIENNA, Vienna, Austria)
08:30T18 - Exploiting Physical Organic Principles in Reaction Design
Ryan GILMOUR
(UNIVERSITY OF MÜNSTER, Münster, Germany)
09:15T19 - Automation, Integration and Miniaturization In Drug Discovery Synthesis
Guido KOCH
(NOVARTIS PHARMA AG, Basel, Switzerland)
10:00OC08 - Exploring New Methods for Facile Synthesis of Some Biologically Interesting Molecules
Ming-Hua XU
(SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES, Shanghai, China)
10:15Coffee Break and Exhibition
10:45T20 - Design and Evolution of New Biocatalysts for Organic Synthesis
Nicholas John TURNER
(UNIVERSITY OF MANCHESTER, Manchester, United Kingdom)
11:30T21 - With Asymmetric Hydrogenation towards a Scalable, Stereoselective Synthesis of Bitopertin
Michelangelo SCALONE
(F. HOFFMANN-LA ROCHE AG, Basel, Switzerland)
12:15OC09 - Development of Synthesis Strategies to DNA-Encoded Compound Libraries - of a Chemoresistant Sequence, and Micellar Nanoreactors
Andreas BRUNSCHWEIGER
(TU DORTMUND, Dortmund, Germany)
12:30Lunch and Exhibition
13:30Poster Session 3
Session chair
Yves P. AUBERSON
(NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, Basel, Switzerland)
14:30T22 - Collaborative Academic/Industrial Research Under the Umbrella of the NSF Center for Selective C-H Functionalization
Huw DAVIES
( EMORY UNIVERSITY, Atlanta, United States)
15:15Roundtable discussion: “Enabling Advances in the Science of Synthesis through Industry-Academic collaborations in the 21st Century”
16:15Coffee Break and Exhibition
16:45Prize Ceremony
Koen AUGUSTYNS
(UNIVERSITY OF ANTWERP, Antwerp, Belgium)
16:50EFMC Prize for a Young Medicinal Chemist in Academia
OC10 - Nature-Derived Peptides as Pharmacological Tools to Design Novel Therapeutics
Christian W. GRUBER
(MEDICAL UNIVERSITY OF VIENNA, Vienna, Austria)
17:35EFMC Prize for a Young Medicinal Chemist in Industry:
OC11 - The Development of non-BET Bromodomain Chemical Probes
Phil HUMPHREYS
(GLAXOSMITHKLINE, Stevenage, United Kingdom)
17:50T23 - Strategies towards Increasing the 3-Dimensionality of the Medicinal Chemistry Design Space
Antonia F. STEPAN
(PFIZER, Biberach, Germany)
18:35Closing of the day
20:00Symposium banquet
Thursday August 31, 2017
Session chair
Karin BRINER
(NOVARTIS, Cambridge, United States)
08:30T24 - Synthetic, Mechanistic and Computational Studies on Reactions of Interest
Scott E. DENMARK
(UNIVERSITY OF ILLINOIS, Urbana, United States)
09:15T25 - More Options, More Complexity: Medicinal Chemistry Mastering Mixed Modalities
Werngard CZECHTIZKY
(SANOFI, Frankfurt, Germany)
10:00OC12 - Discovery of UCB0942, the First Rationally Designed Antiepileptic Drug with a Dual Mechanism of Action for the Treatment of Drug-Resistant Epilepsy
Laurent PROVINS
(UCB, Braine-l'Alleud, Belgium)
10:15Coffee break and Exhibition
10:45T26 - DNA Repair Inhibition in Cancer Therapy: DNA-PK Inhibitor M3814
Thomas FUCHSS
(MERCK KGAA, Darmstadt, Germany)
11:30T27 - Late Stage 18F-Fluorination for PET Imaging
Véronique GOUVERNEUR
(UNIVERSITY OF OXFORD, Oxford, United Kingdom)
12:15Poster Prizes Ceremony
12:30Closing remarks
13:00End of the Symposium

Copyright 2017 LD Organisation  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 10 454777  |   |  VAT: BE 0464819842
Developed and powered by Antalys